Format

Send to

Choose Destination
Biochem Biophys Rep. 2017 Apr 14;10:186-191. doi: 10.1016/j.bbrep.2017.04.004. eCollection 2017 Jul.

Scaffold-free 3D bio-printed human liver tissue stably maintains metabolic functions useful for drug discovery.

Author information

1
Department of Drug Discovery Platform, Cyfuse Biomedical K.K., University of Tokyo, Entrepreneur Plaza, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

Abstract

The liver plays a central role in metabolism. Although many studies have described in vitro liver models for drug discovery, to date, no model has been described that can stably maintain liver function. Here, we used a unique, scaffold-free 3D bio-printing technology to construct a small portion of liver tissue that could stably maintain drug, glucose, and lipid metabolism, in addition to bile acid secretion. This bio-printed normal human liver tissue maintained expression of several kinds of hepatic drug transporters and metabolic enzymes that functioned for several weeks. The bio-printed liver tissue displayed glucose production via cAMP/protein kinase A signaling, which could be suppressed with insulin. Bile acid secretion was also observed from the printed liver tissue, and it accumulated in the culture medium over time. We observed both bile duct and sinusoid-like structures in the bio-printed liver tissue, which suggested that bile acid secretion occurred via a sinusoid-hepatocyte-bile duct route. These results demonstrated that our bio-printed liver tissue was unique, because it exerted diverse liver metabolic functions for several weeks. In future, we expect our bio-printed liver tissue to be applied to developing new models that can be used to improve preclinical predictions of long-term toxicity in humans, generate novel targets for metabolic liver disease, and evaluate biliary excretion in drug development.

KEYWORDS:

3D; 8CPT-cAMP, 8-(4-Chlorophenylthio)adenosine 3′,5′-cyclic monophosphate; Bio-printing; Dex, Dexamethasone; Drug discovery; ECM, Extracellular matrix; HE, hematoxylin and eosin; Liver; MRP2, multidrug resistance-associated protein 2; MT, Masson's trichrome; Metabolism; NAFLD, Non-alcoholic fatty liver disease; NASH, Non-alcoholic steatohepatitis; OAT, organic anion-transporting; Scaffold-free; TUNEL, TdT-mediated dUTP nick end labeling

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center